Skip to main navigation Skip to search Skip to main content

Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen

  • B. A. Khaw
  • , H. W. Strauss
  • , A. Carvalho
  • , E. Locke
  • , H. K. Gold
  • , E. Haber

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

We have developed a method of labeling biologically active labile macromolecules, such as human fibrinogen (HF) and anticardiac-myosin Fab (AM-Fab), with Tc-99m at neutral pH. This method uses dithionite reduction of pertechnetate and subsequent labeling, to test the method with acid-labile macromolecules. Complexes of diethylene triamine pentaacetic acid with macromolecules such as human fibrinogen (D-HF) and anticardiac-myosin Fab (D-AM-Fab) were labeled and utilized in in vitro and in vivo studies. In biodistribution studies, the Tc-99m D-HF had a two-component blood clearance (half-times 1 hr and 15 hr) and was 80-88% coagulable. The Tc-99m AM-Fab retained its immunoreactivity as tested by affinity chromatography; also during in vivo localization in experimental myocardial infarction. This labeling technique provides an easy and efficient approach to the Tc-99m labeling of other biologically active and acid-labile macromolecules.

Original languageEnglish
Pages (from-to)1011-1019
Number of pages9
JournalJournal of Nuclear Medicine
Volume23
Issue number11
StatePublished - 1982
Externally publishedYes

Fingerprint

Dive into the research topics of 'Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen'. Together they form a unique fingerprint.

Cite this